Ticker Details
Bicara Therapeutics Inc. Common Stock
IPO Date:	September 13, 2024
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$1.42B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.54 | 3.43%
Avg Daily Range (30 D):	$0.55 | 2.50%
Avg Daily Range (90 D):	$0.45 | 2.38%

Institutional Daily Volume
Avg Daily Volume:	.48M
Avg Daily Volume (30 D):	.41M
Avg Daily Volume (90 D):	.42M

Trade Size
Avg Trade Size (Sh.):	71
Avg Trade Size (Sh.) (30 D):	50
Avg Trade Size (Sh.) (90 D):	55

Institutional Trades
Total Institutional Trades:	482
Avg Institutional Trade:	$1.52M
Avg Institutional Trade (30 D):	$1.43M
Avg Institutional Trade (90 D):	$1.41M
Avg Institutional Trade Volume:	.1M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.57M
Avg Closing Trade (30 D):	$1.58M
Avg Closing Trade (90 D):	$1.56M
Avg Closing Volume:	97.26K

News

Feb 26, 2026 @ 9:01 PM Bicara Therapeutics Announces Closing of Oversubsc... Source: Globe Newswire

Feb 25, 2026 @ 4:13 AM Bicara Therapeutics Announces Pricing of $150 Mill... Source: Na

Feb 24, 2026 @ 9:01 PM Bicara Therapeutics Announces Proposed Public Offe... Source: Globe Newswire

Dec 15, 2025 @ 1:00 PM Bicara Therapeutics to Present at the J.P. Morgan ... Source: Claire Mazumdar

Dec 6, 2025 @ 1:00 PM Bicara Therapeutics’ Preliminary Phase 1b E... Source: Bicara Therapeutics

Financials
	TTM	Q1 2026	Q4 2025
Basic EPS	$-2.78	$-.93	$-.68
Diluted EPS	$-2.78	$-.93	$-.68
Revenue	$M	$M	$M
Gross Profit
Net Income / Loss	$-157.32M	$-56.21M	$-37.39M
Operating Income / Loss	$-174.06M	$-60.24M	$-41.12M
Cost of Revenue
Net Cash Flow	$-166.25M	$226.78M	$-74.99M
PE Ratio